Caris Life Sciences Q1 Sales $216.174M Beat $210.292M Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings BeatsNews
Caris Life Sciences (NASDAQ:CAI) reported quarterly sales of $216.174 million which beat the analyst consensus estimate of $210.292 million by 2.80 percent. This is a 78.78 percent increase over sales of $120.915
Caris Life Sciences (NASDAQ:CAI) reported quarterly sales of $216.174 million which beat the analyst consensus estimate of $210.292 million by 2.80 percent. This is a 78.78 percent increase over sales of $120.915 million the same period last year.